The protective effect of human atrial natriuretic peptide on renal damage during cardiac surgery

Journal of Anesthesia

Volumn 31, Issue 2, 2017, Pages 163-169

  Moriyama, Takahiro ^a   Hagihara, Shintaro ^a   Shiramomo, Toko ^a   Nagaoka, Misaki ^b   Iwakawa, Shohei ^a   Kanmura, Yuichi ^a  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b Department of Anesthesiology and Critical Care Medicine ^*  (Japan)

Author keywords

Acute kidney injury; Cardiac surgery; Human atrial natriuretic peptide; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR ALPHA; CREATININE; FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ATRIAL NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HEART SURGERY; HUMAN; INCIDENCE; KIDNEY INJURY; MALE; MIDDLE AGED; PLASMA RENIN ACTIVITY; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; BLOOD; CONTROLLED STUDY; DRUG EFFECTS; KIDNEY; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; URINE;

ACUTE KIDNEY INJURY; AGED; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD;

EID: 84995370834     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-016-2284-0     Document Type: Article

References (29)

1. Gaffney AM, Sladen RN. Acute kidney injury in cardiac surgery. Curr Opin Anaesthesiol. 2015;28:50–9.
2. Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo M, Salandin V, Da Ros A, Michieletto F, Simini G. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;17:1489–95.
3. Corwin HL, Sprague SM, DeLaria GA, Norusis MJ. Acute renal failure associated with cardiac operations. A case-control study. J Thorac Cardiovasc Surg. 1989;98:1107–12.
4. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ. Bihorac. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444–53.
5. Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Eng J Med. 1986;314:97–105.
6. De Bold AJ. Heart atria granularity effects of changes in water-electrolyte balance. Proc Soc Exp Biol Med. 1979;161:508–11.
7. Sezai A, Shiono M, Orime Y, Hata H, Hata M, Negishi N, Sezai Y. Low-dose continuous infusion of human atrial natriuretic peptide during cardiac surgery. Ann Thorac Surg. 2009;54:1058–64.
8. Sezai A, Hata M, Niino T, Yoshitake I, Unosawa S, Wakui S, Osaka S, Takayama T, Kasamaki Y, Hirayama A, Minami K. Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study. J Am Coll Cardiol. 2009;54:1058–64.
9. Mitaka C, Kudo T, Jibiki M, Sugano N, Inoue Y, Makita K, Imai T. Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair. Crit Care Med. 2008;36:745–51.
10. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251–87.
11. Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009;53:344–50.
12. Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JMS, AKInet Investigators. Urinary angiotensinogen and risk of severe AKI. Clin L Am Soc Nephrol. 2013;8:184–93.
13. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
14. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012 2:1–138.
15. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15:1597–605.
16. Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int. 1985;27:928–37.
17. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean M, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–8.
18. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54:1012–24.
19. Portilla D, Dent C, Sugaya T, Nagothu KK, Kundi I, Moore P, Noiri E, Devarajan P. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008;73:465–72.
20. Matsui K, Kamijo-Ikemori A, Sugaya T, Yasuda T, Kimura K. Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults. Circ J. 2012;76:213–20.
21. Moriyama T, Kanmura Y, Lindahl SG. Atrial natriuretic peptide attenuation of renal ischemia-reperfusion injury after major surgery. J Surg Res. 2016;201:213–8.
22. Abadir PM, Walston JD, Carey RM. Subcellular characteristics of functional intracellular renin-angiotensin systems. Peptides. 2012;38:432–45.
23. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med. 2004;32:1310–5.
24. Lassnig A, Schmid ER, Hiesmayr M, Falk C, Druml W, Bauer P, Schmidlin D. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care. 2008;36:1129–37.
25. Liotta M, Olsson D, Sartipy U, Holzmann MJ. Minimal changes in postoperative creatinine values and early and late mortality and cardiovascular events after coronary artery bypass grafting. Am J Cardiol. 2014;113:70–5.
26. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534–43.
27. Matsui K, Kamijo-Ikemorif A, Sugaya T, Yasuda T, Kimura K. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Am J Pathol. 2011;178:1021–32.
28. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshida T, Ogawa Y, Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009;75:285–94.
29. Efrati S, Berman S, Abu Hamad R, EI Nakib R, Chanimov M, Siman-Tov Y, Weissgarten J. Hyperglycaemia, inflammation, RAS activation: three culprits to blame for acute kidney injury emerging in healthy rats during general anesthesia. Nephrology. 2012;17:591–602.